Delhi High Court rejects Novo Nordisk's plea for interim injunction against Dr Reddy's Labs over semaglutide. Court cites 'evergreening', allows DRL to export. Key ruling for diabetes drug market.
HSBC sees Dr Reddy's Canada semaglutide opportunity intact. Goldman Sachs bullish on Titan's 15-20% jewellery growth. CLSA positive on Power Grid's battery storage entry. Get the full analysis.
Leading brokerages HSBC, Jefferies, Citigroup, Kotak, and Goldman Sachs release ratings on GAIL, Kfin Tech, Laurus Labs, Swiggy, and Jubilant FoodWorks. Get key target prices and investment insights.
Modern forensic tools are transforming crime investigation in India, but under-resourced labs face challenges meeting rising demand. Explore the forensic science dilemma.
Dr Reddy's Laboratories secures European Commission marketing authorisation for AVT03, its denosumab biosimilar for osteoporosis treatment across EU markets. Learn about this major regulatory milestone.
The US completes critical B61-12 nuclear gravity bomb flight tests using the F-35A stealth fighter, validating its operational readiness for future nuclear missions.
Discover how Dr. Anji Reddy's visionary journey from generics to innovative drug research positioned India as a global pharmaceutical powerhouse and continues to inspire future generations.